SOFT-EST
Clinical Trial Program
Estrogen suppression substudy. Investigating estrogen suppression for patients participating in the SOFT trial – Arms B and C
Phase III
Status
Finished
Tumour subtype:
HR+
Scenario
Adjuvant
SPONSOR
COLLABORATORS
PRINCIPAL INVESTIGATORS
Prue Francis, MD (Meter MacCallum Cancer Institute)
Gini Fleming, MD (University of Chicago Medical Center)
Sites
